|
|
![]() |
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Research Article |
Departments of Virology and Pathology, Haartman Institute and Biomedicum Helsinki, University of Helsinki and Helsinki University Hospital, FIN-00014 Helsinki, Finland
* Author for correspondence (e-mail: jorma.keski-oja{at}helsinki.fi)
Accepted 10 June 2002
Latent TGF-ß-binding proteins (LTBPs) were initially identified
through their binding to the growth factor. Three of the four known LTBPs are
able to associate covalently with the small latent forms of TGF-ß and
mediate their efficient secretion. LTBPs have subsequently been found to
associate with the extracellular matrix. We report here the cDNA cloning and
characterization of the human LTBP-3 protein, which is the smallest LTBP. The
hLTBP-3 gene consists of 28 exons, including one alternatively
spliced exon. The splice variant contains an additional
epidermal-growth-factor-like repeat in the C-terminus. The gene is transcribed
to produce a
4.6 kb mRNA, which is expressed at high levels in human
heart, skeletal muscle, prostate and ovaries and in certain osteosarcoma and
fibroblastic cell lines. Antibodies were generated against recombinant
fragment of hLTBP-3 and used to detect the protein and its secretion from
cultured COS-7 and osteosarcoma cells. Immunoblotting analysis indicated that
efficient secretion of overexpressed hLTBP-3 from COS-7 cells required
co-expression of TGF-ß1, which resulted in the secretion of high
molecular weight complexes of
240 kDa. hLTBP-3 protein was secreted from
cultured osteosarcoma cells as high molecular weight complexes rather than in
the free form. Similar complexes were recognized with antibodies specific to
ß1LAP. These findings indicate that human LTBP-3 has an essential
role in the secretion and targeting of TGF-ß1.
Key words: LTBP, Latent TGF-ß, Alternative splicing
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
S. B. Anderson, A. L. Goldberg, and M. Whitman Identification of a Novel Pool of Extracellular Pro-myostatin in Skeletal Muscle J. Biol. Chem., March 14, 2008; 283(11): 7027 - 7035. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Koli, M. Myllarniemi, K. Vuorinen, K. Salmenkivi, M. J. Ryynanen, V. L. Kinnula, and J. Keski-Oja Bone Morphogenetic Protein-4 Inhibitor Gremlin Is Overexpressed in Idiopathic Pulmonary Fibrosis Am. J. Pathol., July 1, 2006; 169(1): 61 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul Transforming Growth Factor-{beta}1 to the Bone Endocr. Rev., October 1, 2005; 26(6): 743 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Rifkin Latent Transforming Growth Factor-{beta} (TGF-{beta}) Binding Proteins: Orchestrators of TGF-{beta} Availability J. Biol. Chem., March 4, 2005; 280(9): 7409 - 7412. [Full Text] [PDF] |
||||
![]() |
K. Koli, F. Wempe, A. Sterner-Kock, A. Kantola, M. Komor, W.-K. Hofmann, H. von Melchner, and J. Keski-Oja Disruption of LTBP-4 function reduces TGF-{beta} activation and enhances BMP-4 signaling in the lung J. Cell Biol., October 11, 2004; 167(1): 123 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hyytiainen and J. Keski-Oja Latent TGF-{beta} binding protein LTBP-2 decreases fibroblast adhesion to fibronectin J. Cell Biol., December 22, 2003; 163(6): 1363 - 1374. [Abstract] [Full Text] [PDF] |
||||